APA (7th ed.) Citation

MD, P., CA, N., MM, M., TYM, N., AD, H., W, L., . . . JI, V. (2020). Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization. Cardiovascular research, 116(8), 1434. https://doi.org/10.1093/cvr/cvz247

Chicago Style (17th ed.) Citation

MD, Perry, Ng CA, Mangala MM, Ng TYM, Hines AD, Liang W, Xu MJO, Hill AP, and Vandenberg JI. "Pharmacological Activation of IKr in Models of Long QT Type 2 Risks Overcorrection of Repolarization." Cardiovascular Research 116, no. 8 (2020): 1434. https://doi.org/10.1093/cvr/cvz247.

MLA (9th ed.) Citation

MD, Perry, et al. "Pharmacological Activation of IKr in Models of Long QT Type 2 Risks Overcorrection of Repolarization." Cardiovascular Research, vol. 116, no. 8, 2020, p. 1434, https://doi.org/10.1093/cvr/cvz247.